Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Pharming submits sBLA for Ruconest for prevention of HAE attacks

Nov. 27, 2017

FDA gives orphan drug status to TRM-201 for hemophilic arthropathy

Nov. 22, 2017

BMS-986141 prevents arterial thrombosis in monkeys

Nov. 22, 2017

Desidustat approved as INN for Zydus Cadila's ZYAN-1

Nov. 22, 2017

Genexine's recombinant human erythropoietin effective in patients on dialysis

Nov. 21, 2017

Sumitomo Dainippon Pharma discloses TLR7 antagonists

Nov. 20, 2017

Phase III HAVEN 3 study of emicizumab in hemophilia A meets endpoints

Nov. 20, 2017

FDA first to approve Hemlibra for hemophilia A

Nov. 17, 2017

Shire's Adynovi receives positive opinion in E.U.

Nov. 14, 2017

EMA's CHMP supports expanding Nplate indication

Nov. 13, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...
Circulating sncRNA transcriptome in diabetic kidney disease and SGLT2 inhibitor treatment
BioWorld Science
Small noncoding RNAs (sncRNAs), including miRNAs, piRNAs and snoRNAs, can provide further biological insights into the mechanisms of chronic kidney disease (CKD)...